J
Jean-Marc Guilloit
Publications - 21
Citations - 1181
Jean-Marc Guilloit is an academic researcher. The author has contributed to research in topics: Hyperthermic intraperitoneal chemotherapy & Medicine. The author has an hindex of 9, co-authored 12 publications receiving 970 citations.
Papers
More filters
Journal ArticleDOI
Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
Dominique Elias,Jérémie H. Lefevre,Julie Chevalier,Antoine Brouquet,Frédéric Marchal,Jean-Marc Classe,Gwenael Ferron,Jean-Marc Guilloit,Pierre Meeus,Diane Goéré,Julia Bonastre +10 more
TL;DR: Patients with isolated, resectable PC achieve a median survival of 24 months with modern chemotherapies, but only surgical cytoreduction plus HIPEC is able to prolong median survival to roughly 63 months, with a 5-year survival rate of 51%.
Journal ArticleDOI
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
D. Goéré,D. Goéré,Olivier Glehen,François Quenet,Jean-Marc Guilloit,J.M. Bereder,Gérard Lorimier,Emilie Thibaudeau,Laurent Ghouti,Amandine Pinto,Jean-Jacques Tuech,Reza Kianmanesh,Michel Carretier,Frédéric Marchal,Catherine Arvieux,Cécile Brigand,Pierre Meeus,Patrick Rat,S. Durand-Fontanier,Pascale Mariani,Zaher Lakkis,Valeria Loi,Nicolas Pirro,Charles Sabbagh,M. Texier,Dominique Elias,M. Ducreux,David Malka,Valérie Boige,Ellen Benhamou +29 more
TL;DR: Systematic second-look surgery plus oxaliplatin-HIPEC did not improve disease-free survival compared with standard surveillance and essential surveillance of patients at high risk of developing colorectal peritoneal metastases appears to be adequate and effective in terms of survival outcomes.
Journal ArticleDOI
Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study
Vahan Kepenekian,Dominique Elias,Guillaume Passot,Eliane Mery,Diane Goéré,D. Delroeux,François Quenet,G. Ferron,Denis Pezet,Jean-Marc Guilloit,Pierre Meeus,Marc Pocard,J.M. Bereder,Karine Abboud,Catherine Arvieux,Cécile Brigand,Frédéric Marchal,J-M Classe,Gérard Lorimier,C. de Chaisemartin,Frédéric Guyon,Pascale Mariani,Pablo Ortega-Deballon,S. Isaac,C. Maurice,F. N. Gilly,Olivier Glehen,Gerlinde Averous,Frédéric Bibeau,D. Bouzard,A. Chevallier,S. Croce,Peggy Dartigues,S. Durand-Fontanier,L. Gouthi,Bruno Heyd,R. Kaci,R. Kianmanesh,M. H. Laverrière,Eric Leblanc,B. Lelong,A. Leroux,V. Loi,Christophe Mariette,S. Msika,P. Peyrat,Nicolas Pirro,J. Paineau,F. Poizat,Jack Porcheron,P. Rat,J.-M. Regimbeau,Emilie Thibaudeau,Jean-Jacques Tuech,S. Valmary-Degano,V. Verriele,Philippe Zerbib,Franck Zinzindohoué +57 more
TL;DR: In this paper, the authors evaluated the impact of perioperative systemic chemotherapy strategies on survival and postoperative outcomes in patients with DMPM treated with curative intent with CRS-HIPEC, using a multi-institutional database: the French RENAPE network.
Journal ArticleDOI
Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP- NTC01226394).
Diane Goéré,Olivier Glehen,François Quenet,Michel Ducreux,Jean-Marc Guilloit,M. Texier,Ellen Benhamou,Dominique Elias +7 more
TL;DR: Complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC) allow to prolong survival in patients with colorectal peritoneal metastases (CRPM)...
Journal ArticleDOI
A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application
Laurent Villeneuve,A. Thivolet,Naoual Bakrin,Faheez Mohamed,S. Isaac,Pierre-Jean Valette,Olivier Glehen,P. Rousset,Julio Abba,Karine Abboud,Catherine Arvieux,G. Balague,V. Barrau,Houda Ben Rejeb,J.M. Bereder,Frédéric Bibeau,D. Bouzard,Cécile Brigand,S. Carrere,M. Carretier,C. de Chaisemartin,M. Chassang,A. Chevallier,Thomas Courvoisier,Peggy Dartigues,D. Delroeux,G. Desolneux,A. Dohan,Clarisse Dromain,Frédéric Dumont,S. Durand-Fontanier,Dominique Elias,Clarisse Eveno,S. Evrard,O. Fay,G. Ferron,D. Geffroy,François-Noël Gilly,Julien Fontaine,Nicolas Goasguen,L. Ghouti,Diane Goéré,Jean-Marc Guilloit,Frédéric Guyon,Bruno Heyd,R. Kaci,Mehdi Karoui,R. Kianmanesh,C. Labbé,J. Lacroix,G. Lang-Averous,M. H. Laverrière,Jérémie H. Lefevre,B. Lelong,A. Leroux,Rea Lo Dico,V. Loi,Gérard Lorimier,Frédéric Marchal,A. Mariani,Pascale Mariani,Christophe Mariette,Pierre Meeus,E. Mery,M. Messager,S. Msika,Cédric Nadeau,Pablo Ortega-Deballon,Guillaume Passot,C. Petorin,P. Peyrat,Denis Pezet,Guillaume Piessen,Nicolas Pirro,Marc Pocard,F. Poizat,Jack Porcheron,G. Pourcher,François Quenet,P. Rat,Jean-Marc Regimbeau,P. Rousselot,Charles Sabbagh,Magali Svrcek,R. Tetreau,Emilie Thibaudeau,Jean-Jacques Tuech,S. Valmary-Degano,Delphine Vaudoyer,S. Velasco,V. Verriele-Beurrier,Romuald Wernert,Franck Zinzindohoué +92 more
TL;DR: This application offers computer-assistance to produce simple, quick but precise and standardized pre, intra and postoperative reports of the extent of peritoneal metastases and may help specialized and non-specialized institutions in their current practice but also facilitate research and multicentre studies on peritoneAL surface malignancies.